WallStreetZenWallStreetZen

NASDAQ: TGTX
Tg Therapeutics Inc Stock Ownership - Who owns Tg Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Tg Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Yann EchelardDirector2025-06-1310,000$36.94
$369.40kSell
Sean A. PowerCFO2025-01-0610,021$28.53
$285.94kSell
Sean A. PowerCFO2025-01-0311,337$30.29
$343.44kSell
Laurence N. CharneyDirector2024-11-1125,000$30.20
$754.88kSell
Sagar LonialDirector2024-11-115,000$30.44
$152.20kSell
Yann EchelardDirector2024-11-0520,000$24.48
$489.60kSell

1 of 1

TGTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TGTX insiders and whales buy or sell their stock.

TGTX Shareholders

What type of owners hold Tg Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Michael S. Weiss23.82%37,807,818$1.40BInsider
Blackrock Inc13.54%21,494,972$797.14MInstitution
Vanguard Group Inc9.83%15,604,512$578.69MInstitution
Ra Capital Management LP7.96%12,629,868$468.38MInsider
Lindsay A. Md Rosenwald5.96%9,462,616$350.92MInsider
Biotechnologies Sasu Lfb4.80%7,614,855$282.40MInsider
State Street Corp4.68%7,433,899$275.69MInstitution
Joan Pons Gimbert2.49%3,959,149$146.83MInsider
Geode Capital Management LLC2.07%3,282,567$121.73MInstitution
Soleus Capital Management LP1.79%2,846,703$105.57MInstitution

1 of 3

TGTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TGTX55.59%44.41%Net SellingNet Selling
NUVL75.09%24.91%Net SellingNet Selling
RYTM87.51%12.49%Net SellingNet Selling
AXSM70.09%29.91%Net BuyingNet Selling
TLX0.01%0.00%
View Top Biotech Stocks

Tg Therapeutics Stock Ownership FAQ

Who owns Tg Therapeutics?

Tg Therapeutics (NASDAQ: TGTX) is owned by 61.89% institutional shareholders, 49.44% Tg Therapeutics insiders, and 0.00% retail investors. Michael S. Weiss is the largest individual Tg Therapeutics shareholder, owning 37.81M shares representing 23.82% of the company. Michael S. Weiss's Tg Therapeutics shares are currently valued at $1.40B.

If you're new to stock investing, here's how to buy Tg Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.